American College of Allergy, Asthma and Immunology

What American College of Allergy, Asthma and Immunology does

The American College of Allergy, Asthma and Immunology (ACAAI) is a U.S.-based, nonprofit professional medical association founded in 1942 and headquartered in Arlington Heights, Illinois. It serves more than 6,500 board-certified allergist-immunologists and allied health professionals, functioning as the standard-setting body for the allergy and immunology specialty. Its core mission is delivered through two parallel audiences: (1) a member-facing professional arm providing continuing medical education (CME), Maintenance of Certification (MOC) courses, board preparation, evidence-based Practice Parameters, practice management toolkits (coding, telehealth, prior authorization, RVU, compliance, profitability), advocacy, and the Annual Scientific Meeting; and (2) a patient-facing public arm providing the acaai.org educational website, the Find an Allergist directory, condition-specific decision aids, patient brochures, video resources, and the Allergist Answers newsletter.

ACAAI does not develop proprietary technology products. Its underlying infrastructure consists of two websites (acaai.org for patients, college.acaai.org for members), a learning management system branded as the College Learning Connection, interactive patient tools (e.g., Asthma and Allergy Symptom Test, HOME Allergy Management), and event-management platforms supporting the Annual Scientific Meeting. The most recent strategic focus (as of mid-2026) is addressing a specialty workforce shortage through a joint initiative with AAAAI and the National Medical Association's Allergy, Asthma and Immunology Section, emphasizing expanded training pipelines, team-based care, telehealth, and leadership development.

The College is funded primarily through member dues (a recurring subscription model), Annual Scientific Meeting registration and exhibitor/sponsorship fees, CME/MOC program revenue, and corporate educational grants. There is no parent company, no external ownership stake, and no venture funding — leadership is provided by elected allergist physicians, with Cherie Zachary, MD installed as President on November 9, 2025.

Name

American College of Allergy, Asthma and Immunology

Legal name

American College of Allergy, Asthma & Immunology

Website

https://acaai.org

Company type

Private

Founded year

2026

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

ACAAI is a U.S. nonprofit professional medical association serving 6,500+ allergist-immunologists and allied health professionals with CME, practice guidelines, advocacy, and the Annual Scientific Meeting, while educating patients through acaai.org and the Find an Allergist directory.

Ownership category

akta.pro rank

Headquarters

HQ city

Arlington Heights

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Membership Dues: Professional membership dues from allergist-immunologists and allied health professionals. The College serves over 6,500 members who pay annual membership fees to access resources, CME courses, advocacy services, and practice support.
2. Annual Scientific Meeting: The ACAAI Annual Scientific Meeting generates revenue through registration fees, exhibitor booth fees, and sponsorship opportunities. The 2025 meeting was held in Orlando, Florida (November 6-10, 2025).

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Core offering

ACAAI is a nonprofit professional medical association serving allergist-immunologists and allied health professionals through membership, continuing medical education, practice resources, and advocacy, while providing the public with allergy and asthma education and a directory to board-certified allergists. It generates revenue primarily through member dues and its Annual Scientific Meeting, and it sets clinical standards through Practice Parameters guidelines.

Product overview

The American College of Allergy, Asthma and Immunology (ACAAI) is a professional medical association of more than 6,500 allergist-immunologists. Rather than a single commercial technology product, ACAAI operates a portfolio of member services and patient education resources. The core offerings include: the public patient website (acaai.org) with educational content and the Find an Allergist locator tool; the member-only portal (college.acaai.org) providing CME/MOC education, coding toolkits, and practice management resources; the HOME (Home Allergy Management) interactive tool; the Allergist Answers newsletter; Type 2 Connection clinical resources; Practice Parameters evidence-based guidelines; and the Annual Scientific Meeting. These resources work together to serve both patients seeking allergy/asthma care and allergist members seeking professional development and practice support.

Differentiator

Problem solved

Functional benefit

Brands

• ACAAI Annual Scientific Meeting: Annual Scientific Meeting held annually for allergist-immunologists featuring presentations of clinical research, educational sessions, and networking opportunities.
• ACAAI Patient
• ACAAI College

Products and services

• ACAAI Public Patient Website (acaai.org) The main public-facing website providing allergy and asthma educational resources, symptom information, treatment guidance, and a Find an Allergist locator tool for patients seeking information and access to board-certified allergists.
• ACAAI Member Website (college.acaai.org) The member-only portal for allergist-immunologists providing continuing medical education (CME), MOC courses, board preparation tools, clinical resources, coding toolkits, practice management resources, and publications for ACAAI members.
• Find an Allergist Directory A searchable online directory allowing patients to locate board-certified allergist-immunologists in their area, available on acaai.org for patient self-service.
• College Learning Connection An online education platform offering CME and MOC courses, board preparation tools, and clinical resources for allergist-immunologists practicing in the United States and internationally.
• Practice Parameters Evidence-based clinical guidelines developed with the Joint Taskforce on Practice Parameters that establish standards for diagnosis and management of allergic and immunologic diseases, used by allergist-immunologists and other clinicians.
• Professional Toolkits (Coding, Telehealth, Prior Authorization, RVU, Risk and Compliance, Marketing, Practice Profitability) A collection of downloadable toolkits for ACAAI members including Coding Toolkit, Telehealth Toolkit, Prior Authorization Toolkit, Risk and Compliance Toolkit, RVU Toolkit, Marketing and Patient Materials Toolkit, and Practice Profitability Toolkit to support practice management for allergy and immunology practices.
• ACAAI Annual Scientific Meeting The ACAAI Annual Scientific Meeting providing education, networking, and research presentation opportunities for allergist-immunologists, with the 2025 meeting held in Orlando, Florida (November 6-10, 2025) and registration, exhibitor, and sponsorship fees supporting the College's mission.
• Interactive Patient Tools (Decision Aids and Symptom Tests) Web-based interactive tools including the Asthma and Allergy Symptom Test quiz, Controlling Your Severe Asthma tool, Controlling Your Eczema (Atopic Dermatitis) tool, Treating Chronic Rhinosinusitis with Nasal Polyps tool, and a Should I Treat My Allergies With Immunotherapy decision aid used by patients considering allergy care.
• HOME (Home Allergy Management) Online Tool An online educational tool designed to educate allergy sufferers on identifying and managing indoor allergens within the home environment.
• Type 2 Connection Resources A clinical resource helping healthcare providers understand the Type 2 inflammation connection and its implications across allergic rhinitis, asthma, eczema, CRSwNP, eosinophilic esophagitis, and food allergies.
• Allergist Answers Newsletter An email newsletter from the College providing allergy and asthma information to patients and caregivers, with seasonal updates such as Spring 2026 content covering Asthma and Allergy Awareness Month.
• Español Resources (Spanish-language website and materials) Spanish-language version of the ACAAI public website and resources covering asthma information, allergy basics, vaccine information, and early peanut introduction guidance for Spanish-speaking patients and caregivers.

Named customers3 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Six partnerships are on record, tiered flagship and minor.

• National Medical Association Allergy, Asthma and Immunology SectionflagshipStrategic or Co-development Partner · 9 June 2026Joint call to action issued by leaders from the National Medical Association Allergy, Asthma and Immunology Section, AAAAI, and ACAAI to strengthen and expand the specialty workforce to meet growing demand for allergy and immunology care. The collaboration focuses on expanded training pipelines, team-based care models, AI-powered telehealth, and leadership development.
• American Academy of Allergy, Asthma & Immunology (AAAI)flagshipStrategic or Co-development Partner · 9 June 2026Joint call to action with AAAAI and NMA to address workforce challenges in allergy/immunology specialty. Organizations highlighted proven approaches including expanded training pipelines, team-based care models, AI-powered telehealth, and leadership development.
• Nektar TherapeuticsminorOthers · 8 November 2025Nektar Therapeutics presented new data from Rezpegaldesleukin study at ACAAI 2025 Annual Scientific Meeting. The company is developing immunological treatments for autoimmune and chronic inflammatory diseases.
• Ionis PharmaceuticalsminorOthers · 7 November 2025Ionis Pharmaceuticals presented long-term data for DAWNZERA (donidalorsen) at ACAAI 2025 Annual Scientific Meeting. DAWNZERA is an RNA-targeted medicine for hereditary angioedema (HAE) approved by FDA for patients 12 and older.
• ARS PharmaceuticalsminorOthers · 3 November 2025ARS Pharmaceuticals presented real-world data on its intranasal epinephrine spray, neffy, at ACAAI 2025 Annual Scientific Meeting. Presentations included clinical results supporting effectiveness and safety in treating allergic reactions including anaphylaxis.
• PharvarisminorOthers · 23 October 2025Pharvaris presented clinical data on oral bradykinin B2 receptor antagonists for hereditary angioedema at ACAAI 2025 Annual Scientific Meeting in Orlando, Florida (November 6-10, 2025).

Scale indicators5 records

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• American College of Physicians (ACP): ACP is a major US internal medicine professional society offering CME, MOC, and practice resources to a much larger physician base. It is a broad incumbent peer to ACAAI as a model for specialty-society operations, member engagement, and practice management toolkits.
• American Medical Association (AMA): AMA is the largest US physician membership organization, providing CME, advocacy, and practice resources. It is a broad incumbent peer because it competes for the same physician dues dollar and provides cross-specialty digital education that overlaps with ACAAI's CME/MOC portfolio.
• American Thoracic Society (ATS): ATS is a US medical professional society for pulmonary, critical care, and sleep medicine, with comparable CME, journals, and advocacy functions. It is a broad incumbent peer that intersects with ACAAI on asthma-related clinical guidance and industry-funded educational programs.
• American College of Chest Physicians (CHEST): CHEST is a US physician specialty society covering pulmonology, critical care, and sleep medicine with a large annual meeting and CME catalog. It is a broad-incumbent peer because it overlaps with ACAAI on respiratory topics (asthma) and competes for industry CME/sponsorship dollars, though it is not allergy-specific.
• American Academy of Pediatrics (AAP): AAP is a large US professional association for pediatricians with extensive CME, practice parameters, and patient education resources. It is a broad incumbent peer because it covers pediatric allergy/asthma and competes with ACAAI for member attention, CME spend, and industry sponsorship.

Emerging players

• Society for Immunotherapy of Cancer (SITC): SITC is a US professional society focused on cancer immunotherapy, with comparable CME, annual meeting, and industry partnership models. It is an emerging peer as a specialty society with overlapping immunology content and competing for industry exhibitor and sponsorship dollars relevant to ACAAI's immunology-adjacent meeting portfolio.
• American College of Rheumatology (ACR): ACR is a US professional society for rheumatologists, with a similar CME, MOC, practice parameter, and Annual Meeting model to ACAAI. It is an emerging peer as a fellow specialty society with comparable immunology content and industry funding dynamics, though serving a different clinical specialty.
• Joint Council of Allergy, Asthma & Immunology: The Joint Council of Allergy, Asthma & Immunology is a smaller US organization focused on advocacy and practice economics in the allergy/immunology specialty. It is an emerging peer because it operates in the same specialty space as ACAAI but is narrower in scope, focused on practice economics rather than full-spectrum CME and patient education.

Regional players

• European Academy of Allergy and Clinical Immunology (EAACI): EAACI is the leading European professional society for allergists and clinical immunologists, offering comparable congresses, CME, and clinical guidelines. It is a regional peer to ACAAI in the same specialty but operating primarily across Europe rather than directly competing in the US market.

Direct peers

• American Academy of Allergy, Asthma & Immunology (AAAI): AAAI is the other major US professional medical association serving allergist-immunologists, with overlapping CME, advocacy, and Annual Meeting offerings. It is ACAAI's closest direct competitor for members, industry sponsorships, and policy influence, and the two collaborated on the 2026 joint workforce call to action.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/ACAAI
• YouTubeyoutube.com/user/allergists
• Facebookfacebook.com/TheACAAI
• LinkedInlinkedin.com/groups/2443914
• Instagraminstagram.com/allergy_acaai
• Pinterestpinterest.com/acaai

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about American College of Allergy, Asthma and Immunology